Corteqa operates at the vanguard of neurodiagnostic innovation. By integrating neuroscience and technology with clinical expertise, Corteqa delivers high-precision, evidence-based assessments for autism, ADHD and other complex neurodevelopmental conditions. A rigorous, transdiagnostic approach across the lifespan optimises interpretative insights for patients, clinicians and academic collaborators. Founded by a Cambridge University neuroscientist, Corteqa operates within a professor and consultant psychiatrist-led framework and is supported by a multidisciplinary research network. Clinical oversight is provided by Professor Ashok Roy OBE.